"10.1371_journal.pone.0064073","plos one","2013-05-28T00:00:00Z","Nirianne Marie Q Palacpac; Edward Ntege; Adoke Yeka; Betty Balikagala; Nahoko Suzuki; Hiroki Shirai; Masanori Yagi; Kazuya Ito; Wakaba Fukushima; Yoshio Hirota; Christopher Nsereko; Takuya Okada; Bernard N Kanoi; Kohhei Tetsutani; Nobuko Arisue; Sawako Itagaki; Takahiro Tougan; Ken J Ishii; Shigeharu Ueda; Thomas G Egwang; Toshihiro Horii","Department of Molecular Protozoology, Research Institute for Microbial Diseases, Osaka University, Suita, Osaka, Japan; The Research Foundation for Microbial Diseases of Osaka University, Suita, Osaka, Japan; Med Biotech Laboratories, Kampala, Uganda; Makerere University School of Public Health, Kampala, Uganda; The Research Foundation for Microbial Diseases of Osaka University, Kanonji, Kagawa, Japan; Department of Public Health, Faculty of Medicine, Osaka City University, Osaka, Japan; Sumida Hospital, Medical Co. Living Together Association (LTA) Clinical Pharmacology Center, Tokyo, Japan; Lira Medical Centre, Lira, Uganda; Laboratory of Adjuvant Innovation, National Institute of Biomedical Innovation, Ibaraki City, Osaka, Japan; Laboratory of Vaccine Science, Immunology Frontier Research Center, World Premier Institute for Immunology, Osaka University, Suita, Osaka, Japan","Conceived and designed the experiments: TH KJI NMQP NS TO KT HS. Performed the experiments: TGE AY EN BB CN HS NS NMQP TO MY. Analyzed the data: TH NMQP NS KI WF YH. Contributed reagents/materials/analysis tools: SU HS KT NMQP NS TO MY NA SI TT KI. Wrote the paper: TH NMQP KJI AY TGE KI TT EN. Regulatory and ethical submissions: EN TGE NS SU HS TO NMQP.","TH and BIKEN hold patent for BK-SE36. BIKEN provided funding for this study. SU is a member of the Board of Directors of BIKEN. HS (Department Manager, Production Technology Department), NS and TO are/were employees of BIKEN. KT was a former consigned staff of BIKEN and NMQP was employed as a researcher of BIKEN during the trial conduct. TGE (Principal Investigator), AY (Co-Principal Investigator), Clinical investigators: EN, CN and BB; and BNK (Laboratory Technical Supervisor) received honoraria from BIKEN to undertake the clinical trial and follow-up study. TH and KJI are medical advisers of the clinical trial but have not received any honoraria or personal payment from BIKEN. These do not alter the authorsâ€™ adherence to all PLOS ONE policies on sharing data and materials. None of the other authors have competing interests.","2013","05","Nirianne Marie Q Palacpac","NMQP",21,TRUE,7,10,6,8,TRUE,TRUE,TRUE,1,"13",FALSE
